Genmab | GEN - EPS Прибыль на акцию


Fiscal Календарь Фактический Консенсус Предыдущий Дата
FY2025Q2 Jun/2025 34.31 26.44 21.70 Aug/07
FY2025Q1 Mar/2025 20.19 16.27 20.18 May/08
FY2024Q4 Dec/2024 59.49 24.90 9.66 Feb/12
FY2024Q3 Sep/2024 19.94 21.70 32.46 Nov/06
FY2024Q2 Jun/2024 21.70 21.35 20.61 Aug/08




Eps Изменить Дата
Agios Pharmaceuticals USD -1.69 0 2026-06
Almirall EUR 0.07 0.03 2025-12
Amarin USD 0.14 0.06 2025-12
Amgen USD 6.29 1.14 2026-06
argenx SE USD 6.44 1.74 2026-06
AstraZeneca USD 2.63 0.05 2026-06
Bayer EUR 0.95 1.76 2026-06
BioMarin Pharmaceutical USD 1.2 0.44 2026-06
Demant DKK 6.3 0.2 2026-06
Exelixis USD 0.91 0.04 2026-06
Fresenius Medical Care EUR 1.12 0.21 2026-06
Genmab DKK 5.43 4.6 2026-06
GlaxoSmithKline GBP 0.51 0.08 2026-06
GN Store Nord DKK -1.48 1.17 2026-06
GRIFOLS EUR 0.23 0.09 2026-06
Hikma Pharmaceutical USD 0.65 0.12 2025-12
Insmed USD -0.06 0.7 2026-06
Lakefront Biotherapeutics EUR -0.2 0.64 2026-06
Lonza CHF 6.07 1.92 2025-06
Merck EUR -0.54 2.65 2026-06
Novartis USD 2.41 0.42 2026-06
Regeneron Pharmaceuticals USD 14.29 4.82 2026-06
Roche Holding CHF 10.98 2.61 2026-06
Sanofi EUR 2.09 0.21 2026-06
UCB EUR 5.65 3.21 2025-12